H A R E S I G N

Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.

Contact Info
Connect

LinkedIn

Primary care consulting for GP practices & PCNs across England. Get in touch →

MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd)

Published
23 April 2026
Source
PSNC Dispensing & Supply News
Imported
6 Jun 2026

Update 24/04/2026: Perrigo supplied the incorrect expiry date for one of the batches. This has been corrected in the table below, highlighted in red.  MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd) Drug Alert Number: EL(25)A/21 Date issued: 23 April 2026 Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant [...]

The post MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd) appeared first on Community Pharmacy England.

View Original Alert
Important: This alert is aggregated automatically for information only. Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest

Back to Safety Alerts